In the past six months, several stocks have demonstrated impressive performance, particularly in the Pharmaceuticals & Biotechnology and Capital Markets sectors. Leading the pack is Oramed Pharmaceuticals, Inc., a Micro Cap company in the Pharmaceuticals & Biotechnology sector, which achieved a remarkable return of 60.85%. This significant growth highlights the potential of innovative companies within the healthcare space. Following closely is Federated Hermes, Inc., categorized as a Small Cap firm in the Capital Markets sector. This company recorded a return of 7.25%, showcasing steady performance amidst a fluctuating market environment. In contrast, Robinhood Markets, Inc., a Large Cap player also in the Capital Markets sector, experienced a decline with a return of -12.84%. This downturn reflects the challenges faced by some larger firms in the current economic landscape. Overall, these stocks illustrate the diverse performance trends across different market segments, with Oramed Pharmaceuticals standing out as a top performer in recent months.